Piperidine-4-sulphonic acid, a new specific GABA agonist.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 7354350)

Published in J Neurochem on March 01, 1980

Authors

P Krogsgaard-Larsen, E Falch, A Schousboe, D R Curtis, D Lodge

Articles by these authors

Amino acid transmitters in the mammalian central nervous system. Ergeb Physiol (1974) 5.99

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science (1988) 4.00

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol (1983) 3.69

GABA, bicuculline and central inhibition. Nature (1970) 3.55

Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res (1971) 3.52

Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem (1984) 3.39

The structure of bovine rhodopsin. Biophys Struct Mech (1983) 3.33

Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci (2000) 3.10

The hyperpolarization of spinal motoneurones by glycine and related amino acids. Exp Brain Res (1968) 3.00

A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp Brain Res (1968) 2.95

The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacol Rev (1965) 2.81

A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature (1997) 2.74

The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48

Kainate receptors are involved in synaptic plasticity. Nature (1999) 2.43

The specificity of strychnine as a glycine antagonist in the mammalian spinal cord. Exp Brain Res (1971) 2.41

Antagonism between bicuculline and GABA in the cat brain. Brain Res (1971) 2.29

Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci (1990) 2.21

Central synaptic transmission--microelectrophoretic studies. Annu Rev Pharmacol (1969) 2.17

Pharmacological studies on feline Betz cells. J Physiol (1966) 2.11

Spinal interneurone excitation by conformationally restricted analogues of L-glutamic acid. Nature (1974) 2.09

The acetylcholine receptors of Renshaw cells. Exp Brain Res (1966) 1.87

An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? Nature (1985) 1.81

The synaptic excitation of Renshaw cells. Exp Brain Res (1966) 1.74

High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol (1997) 1.73

Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem (1975) 1.67

Phaclofen: a peripheral and central baclofen antagonist. Brain Res (1987) 1.66

Astrocytes: glutamate producers for neurons. J Neurosci Res (1999) 1.62

Tetanus toxin and spinal inhibition. Brain Res (1968) 1.59

Ligands for glutamate receptors: design and therapeutic prospects. J Med Chem (2000) 1.58

Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res (1987) 1.58

Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. Mol Pharmacol (1994) 1.57

Excitation of mammalian central neurones by acidic amino acids. Brain Res (1972) 1.52

The excitation of Renshaw cells by cholinomimetics. Exp Brain Res (1966) 1.48

The antagonism of amino acid-induced excitation of spinal neurones in the cat. Brain Res (1979) 1.47

The effect of bicuculline upon synaptic inhibition in the cerebral and cerebellar corticles of the cat. Brain Res (1971) 1.47

Proceedings: Rhythmical field potentials induced in the inferior olive complex by iontophoretically applied harmaline and other unrelated alkaloids. Br J Pharmacol (1973) 1.45

Neuropharmacology of AMPA and kainate receptors. Neuropharmacology (1999) 1.43

Bicuculline methochloride as a GABA antagonist. Nat New Biol (1972) 1.40

New class of glutamate agonist structurally related to ibotenic acid. Nature (1980) 1.38

Epileptiform activity induced by alkalosis in rat neocortical slices: block by antagonists of N-methyl-D-aspartate. Neurosci Lett (1987) 1.36

Structure and biological activity of a series of conformationally restricted analogues of GABA. J Neurochem (1975) 1.32

Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology (1996) 1.32

Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J Neurochem (1983) 1.31

Tetanus toxin and the synaptic release of GABA. Brain Res (1973) 1.31

The inactivation of extracellularly administered amino acids in the feline spinal cord. Exp Brain Res (1970) 1.31

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology (1993) 1.31

Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors. Mol Pharmacol (1997) 1.30

Direct demonstration by [13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons. Neurochem Int (1993) 1.28

A new class of GABA agonist. Nature (1977) 1.28

Inhibition of the uptake of GABA and related amino acids in rat brain slices by the optical isomers of nipecotic acid. J Neurochem (1976) 1.28

Dantrolene prevents glutamate cytotoxicity and Ca2+ release from intracellular stores in cultured cerebral cortical neurons. J Neurochem (1991) 1.27

A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP. Neuron (2001) 1.27

Selective effects of (-)-baclofen on spinal synaptic transmission in the cat. Exp Brain Res (1981) 1.26

The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology (1998) 1.25

Acetylcholine sensitivity of cerebellar neurones in the cat. J Physiol (1966) 1.24

Bicuculline and central GABA receptors. Nature (1970) 1.23

The first immunoglobulin-like neural cell adhesion molecule (NCAM) domain is involved in double-reciprocal interaction with the second immunoglobulin-like NCAM domain and in heparin binding. J Biol Chem (1997) 1.22

Effects of ketamine and three other anaesthetics on spinal reflexes and inhibitions in the cat. Br J Anaesth (1984) 1.21

The in vivo inactivation of GABA and other inhibitory amino acids in the cat nervous system. Exp Brain Res (1976) 1.20

DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists. Neuropharmacology (1999) 1.20

Comparison of sigma- and kappa-opiate receptor ligands as excitatory amino acid antagonists. Br J Pharmacol (1984) 1.20

Convulsive action of penicillin. Brain Res (1972) 1.19

Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia. J Neurochem (1997) 1.19

The pharmacology of the inhibition of dorsal horn neurones by impulses in myelinated cutaneous afferents in the cat. Exp Brain Res (1975) 1.19

Pharmacological studies upon spinal presynaptic fibres. Exp Brain Res (1966) 1.18

The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem (1999) 1.18

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett (1995) 1.17

Central effects of beta-(para-chlorophenyl)-gamma-aminobutyric acid. Brain Res (1974) 1.17

Inhibition of spinal neurons by glycine. Nature (1967) 1.17

Central actions of benzodiazepines. Brain Res (1976) 1.16

Experimental studies of the influence of vigabatrin on the GABA system. Br J Clin Pharmacol (1989) 1.15

Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro. Neuropharmacology (1985) 1.14

GABA and hippocampal inhibition. Br J Pharmacol (1970) 1.14

The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int (2000) 1.13

A central action of hemicholinium. Nature (1965) 1.13

Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J Neurochem (1987) 1.13

Betel nut constituents as inhibitors of gamma-aminobutyric acid uptake. Nature (1975) 1.12

Selective antagonism by D-alpha-aminoadipate of amino acid and synaptic excitation of cat spinal neurons. Brain Res (1978) 1.12

Drug-induced rhythmical activity in the inferior olivary complex of the rat. Brain Res (1976) 1.12

Glutamate transport and metabolism in astrocytes. Glia (1997) 1.11

Metabolic fate of 14C-labeled glutamate in astrocytes in primary cultures. J Neurochem (1982) 1.11

The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent. J Neurochem (1999) 1.11

Transport and metabolism of glutamate and GABA in neurons are glial cells. Int Rev Neurobiol (1981) 1.11

Studies on field potentials and on single cells in the inferior olivary complex of the rat. Brain Res (1976) 1.10

Securinine alkaloids: a new class of GABA receptor antagonist. Brain Res (1985) 1.09

Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid. J Med Chem (1998) 1.08

Central actions of ibotenic acid and muscimol. Biochem Pharmacol (1968) 1.08

The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus. Neuropharmacology (1999) 1.08

The depolarization of feline ventral horn group Ia spinal afferent terminations by GABA. Exp Brain Res (1982) 1.08

Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem (1975) 1.07